GE HealthCare Technologies Inc. GEHC
85.81 USD +5.15 (+6.38%)
At closeNov 4, 2026, 6:23 PM EST
85.75 -0.06 -0.07%
After hours · Nov 4, 6:23 PM ET
82.89 Day range 87.56
58.75 52-week range 89.77
- YTD
- +4.62%
- 1 year
- +15.49%
Analyst view
Consensus: buy
Buy
Price target (mean) 87.85 +2.4% upside
Now 85.81
- Target (low)
- 75.00
- Target (mean)
- 87.85
- Target (high)
- 100.00
Ratings (0m) 22 16 buy · 6 hold · 0 sell
- Strong buy6
- Buy10
- Hold6
- Sell0
- Strong sell0
Recommendation trend
- This month 22
- 1 month ago 22
- 2 months ago 20
- 3 months ago 19
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.56 | 1.53 – 1.60 | 1.44 | +8.1% | 5.92B | +4.0% | 18 |
| Next quarter | 1.11 | 0.99 – 1.25 | 0.99 | +12.4% | 5.37B | +4.6% | 12 |
| Current year | 5.02 | 4.99 – 5.06 | 4.59 | +9.4% | 21.86B | +6.0% | 21 |
| Next year | 5.50 | 5.09 – 5.65 | 5.02 | +9.4% | 22.93B | +4.9% | 20 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 29, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 29, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 29, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 29, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 28, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 12, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 7, 2026 | Barclays | Initiated | — | Overweight |
| Oct 5, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 5, 2026 | Needham | Reiterated | Buy | Buy |
| Sep 22, 2026 | Needham | Initiated | — | Buy |
| Sep 17, 2026 | BTIG | Reiterated | Buy | Buy |
| Aug 19, 2026 | BTIG | Reiterated | Buy | Buy |
| Jul 31, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 30, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jul 30, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 30, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 29, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 17, 2026 | Hovde Group | Initiated | — | Market Perform |
| Jul 16, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 9, 2026 | BMO Capital | Initiated | — | Market Perform |
| Jun 23, 2026 | RBC Capital | Initiated | — | Outperform |
| May 21, 2026 | UBS | Upgrade | Sell | Neutral |
| Apr 30, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Apr 30, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Apr 30, 2026 | Goldman Sachs | Downgrade | Buy | Neutral |
| Apr 30, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 30, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Apr 30, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 29, 2026 | BTIG | Maintained | Buy | Buy |
